About Aprus Bio-Medical Innovations Private Limited
Data last updated:
Aprus Bio-Medical Innovations Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 09 March 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24233KA2016PTC086773. Its GSTIN is 29AAOCA2278D1ZI (Karnataka).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹8.47 Lakh. It is led by directors including Anand Iyer and Ayyavu Ramachandran.
Its last annual general meeting (AGM) was held on 27 November 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office is at Bangalore Helix Biotech Park Electronic City Phase I, Karnataka, India – 560100.
The company is associated with 1 brand: APRUS Biomedical Innovations. The company has 5 deals on record (2 funding rounds, 2 secondary share transfers, 1 rights issue), with disclosed funding of ₹3.36 Cr; the latest was in July 2017.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website aprus.eco.
Company details
Contact details
Aprus Bio-Medical Innovations Private Limited's registered office is in Bangalore, Karnataka. Its website is aprus.eco. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressBangalore Helix Biotech Park Electronic City Phase I, Karnataka, India – 560100
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Aprus Bio-Medical Innovations Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Aprus Bio-Medical Innovations operates one associated brand: APRUS Biomedical Innovations. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Products for wound care and hygiene markets are developed. | aprus.eco |
Business activity
The main business activity of Aprus Bio-Medical Innovations is professional, scientific and technical. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Aprus Bio-Medical Innovations Private Limited, buy the company report.
Financials of Aprus Bio-Medical Innovations Private Limited
FY 2020 filings availableFinancial Statement Summary
| Metrics | FY 2016-17 | FY 2015-16 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ||
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ||
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2016-17 | FY 2015-16 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | ||
| Net Profit Margin | ||
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Aprus Bio-Medical Innovations Private Limited, buy the company report.
Board of directors of Aprus Bio-Medical Innovations Private Limited
Aprus Bio-Medical Innovations has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anand Iyer Also directs: Tuya Private Limited, Aspis Coatings and Paints Private Limited | Director | 09 Mar 2016 | 10 Years 7 Months | Current |
| Ayyavu Ramachandran Also directs: Paraget Industrial Automation Technology Private Limited | Director | 09 Mar 2016 | 10 Years 7 Months | Current |
| Sunil Shekar Koppa Somashekara Also directs: Tuya Private Limited, Aspis Coatings and Paints Private Limited | Director | 31 Aug 2020 | 6 Years 2 Months | Current |
Auditor
Aprus Bio-Medical Innovations Private Limited is audited by Sachidananda & Co for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Sachidananda & Co | FY 2017 | 015794S |
Shareholding
The shareholding of Aprus Bio-Medical Innovations Private Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Aprus Bio-Medical Innovations Private Limited, buy the company report.
Deals & funding
Aprus Bio-Medical Innovations Private Limited has 5 deals on record (2 funding rounds, 2 secondary share transfers, 1 rights issue), with disclosed funding of ₹3.36 Cr; the latest was in July 2017.
Deals on record (4 of 5)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jul 2017 | Rights issue | ₹5.45 Cr | Investors: 4 individuals Seller: an individual |
| Jul 2017 | Funding round | ₹10 Lakh | Investors: an individual |
| Mar 2017 | Funding round | ₹3.26 Cr | Investors: an individual |
| Mar 2016 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: an individual |
To see the full deal history of Aprus Bio-Medical Innovations Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Aprus Bio-Medical Innovations Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aprus Bio-Medical Innovations Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Aprus Bio-Medical Innovations has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAOCA2278D1ZI | Karnataka | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Aprus Bio-Medical Innovations Private Limited, buy the company report.
Recent activity
Aprus Bio-Medical Innovations Private Limited has 4 board changes on record since 2016: 3 appointments and 1 cessation. The latest: Sunil Shekar Koppa Somashekara ceased to be Additional Director on 27 Nov 2020.
Frequently asked questions
Aprus Bio-Medical Innovations is an active private limited company based in Bangalore, Karnataka, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 09 March 2016 (10+ years old) and is registered under CIN U24233KA2016PTC086773.
Aprus Bio-Medical Innovations has 3 current directors:
- Anand Iyer - Director
- Ayyavu Ramachandran - Director
- Sunil Shekar Koppa Somashekara - Director
The latest financial statements of Aprus Bio-Medical Innovations on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 27 November 2020. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Aprus Bio-Medical Innovations is 29AAOCA2278D1ZI, registered in Karnataka.
The CIN (Corporate Identification Number) of Aprus Bio-Medical Innovations is U24233KA2016PTC086773. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aprus Bio-Medical Innovations was incorporated on 09 March 2016, making it 10+ years old. It is registered with the Registrar of Companies, Bangalore.
Aprus Bio-Medical Innovations has 5 deals on record (2 funding rounds, 2 secondary share transfers, 1 rights issue), with disclosed funding of ₹3.36 Cr; the latest was in July 2017.
Sunil Shekar Koppa Somashekara ceased to be Additional Director on 27 Nov 2020. Sunil Shekar Koppa Somashekara was appointed as Director on 31 Aug 2020. Anand Iyer was appointed as Director on 09 Mar 2016. Aprus Bio-Medical Innovations has 4 board changes on record in total.
Aprus Bio-Medical Innovations can be reached through the website aprus.eco. Its registered office is in Bangalore, Karnataka, India.
The registered office of Aprus Bio-Medical Innovations is at Bangalore Helix Biotech Park Electronic City Phase I, Karnataka, India – 560100.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
